Whole blood manganese concentrations in dogs with congenital portosystemic shunts

Journal of Veterinary Internal Medicine

Volumn 24, Issue 1, 2010, Pages 90-96

  Gow, A G ^a   Marques, A I C ^a   Yool, D A ^a   Duncan, A ^b   Mellanby, R J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Canine; Encephalopathy; Hepatic; Trace element

Indexed keywords

MANGANESE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CONGENITAL MALFORMATION; DOG; DOG DISEASE; FEMALE; LIVER DISEASE; MALE; PORTAL VEIN;

ANIMALS; DOG DISEASES; DOGS; FEMALE; LIVER DISEASES; MALE; MANGANESE; PORTAL SYSTEM;

ANIMALIA; CANIS FAMILIARIS;

EID: 73349096949     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2009.0408.x     Document Type: Article

References (57)

1. Aschner JL, Aschner M. Nutritional aspects of manganese homeostasis. Mol Aspects Med 2005;26:353-362.
2. Finley JW, Davis CD. Manganese deficiency and toxicity: Are high or low dietary amounts of manganese cause for concern? Bio-factors 1999;10:15-24.
3. Roth JA. Homeostatic and toxic mechanisms regulating man-ganese uptake, retention, and elimination. Biol Res 2006;39:45-57.
4. Davis CD, Zech L, Greger JL. Manganese metabolism in rats: An improved methodology for assessing gut endogenous losses. Proc Soc Exp Biol Med 1993;202:103-108.
5. Knopfel M, Zhao L, Garrick MD. Transport of divalent tran-sition-metal ions is lost in small-intestinal tissue of b/b Belgrade rats. Biochemistry 2005;44:3454-3465.
6. Dobson AW, Erikson KM, Aschner M. Manganese neuro-toxicity. Ann NY Acad Sci 2004;1012:115-128.
7. Markesbery WR, Ehmann WD, Hossain TI, et al. Brain man-ganese concentrations in human aging and Alzheimer's disease. Neurotoxicology 1984;5:49-57.
8. Torisu S, Washizu M, Hasegawa D, et al. Measurement of brain trace elements in a dog with a portosystemic shunt: Relation between hyperintensity on T1-weighted magnetic resonance images in lentiform nuclei and brain trace elements. J Vet Med Sci 2008;70:1391-1393.
9. Keen CL, Ensunsa JL, Clegg MS. Manganese metabolism in animals and humans including the toxicity of manganese. Met Ions Biol Syst 2000;37:89-121.
10. Normandin L, Hazell AS. Manganese neurotoxicity: An up-date of pathophysiologic mechanisms. Metab Brain Dis 2002; 17:375-387.
11. Mena I, Marin O, Fuenzalida S, et al. Chronic manganese poisoning. Clinical picture and manganese turnover. Neurology 1967;17:128-136.
12. Komaki H, Maisawa S, Sugai K, et al. Tremor and seizures associated with chronic manganese intoxication. Brain Dev 1999; 21:122-124.
13. Hsieh CT, Liang JS, Peng SS, et al. Seizure associated with total parenteral nutrition-related hypermanganesemia. Pediatr Neurol 2007;36:181-183.
14. Fell JM, Reynolds AP, Meadows N, et al. Manganese toxic-ity in children receiving long-term parenteral nutrition. Lancet 1996;347:1218-1221.
15. Uchino A, Noguchi T, Nomiyama K, et al. Manganese ac-cumulation in the brain: MR imaging. Neuroradiology 2007; 49:715-720.
16. Erikson KM, Shihabi ZK, Aschner JL, et al. Manganese ac-cumulates in iron-deficient rat brain regions in a heterogeneous fashion and is associated with neurochemical alterations. Biol Trace Elem Res 2002;87:143-156.
17. Rose C, Butterworth RF, Zayed J, et al. Manganese deposi-tion in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 1999;117:640-644.
18. Mizoguchi N, Nishimura Y, Ono H, et al. Manganese elevations in blood of children with congenital portosystemic shunts. Eur J Pediatr 2001;160:247-250.
19. Tuschl K, Mills PB, Parsons H, et al. Hepatic cirrhosis, dys-tonia, polycythaemia and hypermanganesaemia-a new metabolic disorder. J Inherit Metab Dis 2008;31:151-163.
20. Layrargues GP, Rose C, Spahr L, et al. Role of manganese in the pathogenesis of portal-systemic encephalopathy. Metab Brain Dis 1998;13:311-317.
21. Versieck J, Barbier F, Speecke A, et al. Manganese, copper, and zinc concentrations in serum and packed blood cells during acute hepatitis, chronic hepatitis, and posthepatitic cirrhosis. Clin Chem 1974;20:1141-1145.
22. Shawcross DL, Olde Damink SW, Butterworth RF, et al. Ammonia and hepatic encephalopathy: The more things change, the more they remain the same. Metab Brain Dis 2005;20:169-179.
23. Shawcross DL, Wright G, Olde Damink SW, et al. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis 2007;22:125-138.
24. Shawcross DL, Davies NA, Williams R, et al. Systemic in-flammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 2004;40:247-254.
25. Ikeda S, Sera Y, Yoshida M, et al. Manganese deposits in patients with biliary atresia after hepatic porto-enterostomy. J Pediatr Surg 2000;35:450-453.
26. Spahr L, Butterworth RF, Fontaine S, et al. Increased blood manganese in cirrhotic patients: Relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. He-patology 1996;24:1116-1120.
27. Torisu S, Washizu M, Hasegawa D, et al. Brain magnetic resonance imaging characteristics in dogs and cats with congenital portosystemic shunts. Vet Radiol Ultrasound 2005;46:447-451.
28. Versieck J, Speecke A, Hoste J, et al. Determination of man-ganese, copper and zinc in serum and packed blood cells by neutron activation analysis. Studies on the metabolism of trace elements. Z Klin Chem Klin Biochem 1973;11:193-196.
29. Versieck J, Speecke A, Hoste J, et al. Trace-element contam-ination in biopsies of the liver. Clin Chem 1973;19:472-475.
30. Pleban PA, Pearson KH. Determination of manganese in whole blood and serum. Clin Chem 1979;25:1915-1918.
31. Krieger D, Krieger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy. Lancet 1995;346:270-274.
32. Shah NJ, Neeb H, Zaitsev M, et al. Quantitative T1 mapping of hepatic encephalopathy using magnetic resonance imaging. He-patology 2003;38:1219-1226.
33. Pujol A, Pujol J, Graus F, et al. Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology 1993;43:65-69.
34. Ikeda S, Yamaguchi Y, Sera Y, et al. Manganese deposition in the globus pallidus in patients with biliary atresia. Transplanta-tion 2000;69:2339-2343.
35. Ihara K, Hijii T, Kuromaru R, et al. High-intensity basal ganglia lesions on T1-weighted images in two toddlers with elevated blood manganese with portosystemic shunts. Neuroradiology 1999;41:195-198.
36. Butterworth RF. Pathophysiology of hepatic encephalopa-thy: The concept of synergism. Hepatol Res 2008;38:S116-S121.
37. Odeh M. Pathogenesis of hepatic encephalopathy: The tumour necrosis factor-alpha theory. Eur J Clin Invest 2007; 37:291-304.
38. Aschner M, Gannon M, Kimelberg HK. Manganese uptake and efflux in cultured rat astrocytes. J Neurochem 1992;58:730-735.
39. Rama Rao KV, Reddy PV, Hazell AS, et al. Manganese induces cell swelling in cultured astrocytes. Neurotoxicology 2007;28:807-812.
40. Hazell AS, Normandin L, Norenberg MD, et al. Alzheimer type II astrocytic changes following sub-acute exposure to manga-nese and its prevention by antioxidant treatment. Neurosci Lett 2006;396:167-171.
41. Milatovic D, Yin Z, Gupta RC, et al. Manganese induces oxidative impairment in cultured rat astrocytes. Toxicol Sci 2007; 98:198-205.
42. Filipov NM, Seegal RF, Lawrence DA. Manganese potenti-ates in vitro production of proinflammatory cytokines and nitric oxide by microglia through a nuclear factor kappa B-dependent mechanism. Toxicol Sci 2005;84:139-148.
43. Jayakumar AR, Rama Rao KV, Kalaiselvi P, et al. Com-bined effects of ammonia and manganese on astrocytes in culture. Neurochem Res 2004;29:2051-2056.
44. Hazell AS, Desjardins P, Butterworth RF. Chronic exposure 51. Tobias KM, Rohrbach BW. Association of breed with the of rat primary astrocyte cultures to manganese results in increased binding sites for the 'peripheral-type' benzodiazepine receptor ligand 3H-PK 11195. Neurosci Lett 1999;271:5-8.
45. Papavasiliou PS, Cotzias GC. Neutron activation analysis: The determination of manganese. J Biol Chem 1961;236:2365-2369.
46. Versieck J, Barbier F, Speecke A, et al. Normal manganese concentrations in human serum. Acta Endocrinol (Copenhagen) 1974;76:783-788.
47. Versieck J, Vanballenberghe L, De Kesel A. More on deter-mination of manganese in biological materials. Clin Chem 1988;34:1659-1660.
48. Versieck J, Barbier F, Cornelis R, et al. Sample contamina-tion as a source of error in trace-element analysis of biological samples. Talanta 1982;29:973-984.
49. Versieck J, Cornelis R, Lemey G, et al. Determination of manganese in whole blood and serum. Clin Chem 1980;26:531-532.
50. Hunt GB. Effect of breed on anatomy of portosystemic shunts resulting from congenital diseases in dogs and cats: A review of 242 cases. Aust Vet J 2004;82:746-749.
51. Tobias KM, Rohrbach BW. Association of breed with the diagnosis of congenital portosystemic shunts in dogs: 2,400 cases (1980-2002). J Am Vet Med Assoc 2003;223:1636-1639.
52. Mert H, Mert N, Dogan I, et al. Element status in different breeds of dogs. Biol Trace Elem Res 2008;125:154-159.
53. Watson PJ, Herrtage ME. Medical management of congen-ital portosystemic shunts in 27 dogs-a retrospective study. J Small Anim Pract 1998;39:62-68.
54. Crossgrove J, Zheng W. Manganese toxicity upon overexpo-sure. NMR Biomed 2004;17:544-553.
55. Herrero Hernandez E, Discalzi G, Valentini C, et al. Follow-up of patients affected by manganese-induced Parkinsonism after treatment with CaNa2EDTA. Neurotoxicology 2006;27:333-339.
56. Ky SQ, Deng HS, Xie PY, et al. A report of two cases of chronic serious manganese poisoning treated with sodium para-aminosalicylic acid. Br J Ind Med 1992;49:66-69.
57. Riordan SM, Williams R. Treatment of hepatic encepha-lopathy. N Engl J Med 1997;337:473-479.